Results 211 to 220 of about 470,839 (363)

Angiotensin‐Converting Enzyme Inhibitors Used Concomitantly with Insulin Secretagogues and the Risk of Serious Hypoglycemia

, 2021
Young Hee Nam, Colleen Brensinger, Warren B. Bilker, James Flory, Charles E. Leonard, Sean Hennessy   +5 more
openalex   +2 more sources

Projecting the benefit of vericiguat in PARADIGM‐HF and DAPA‐HF populations: Insights from the VICTORIA trial

ESC Heart Failure, Volume 12, Issue 2, Page 1479-1484, April 2025.
Abstract Aims The VICTORIA trial demonstrated a significant reduction in the primary composite outcome of heart failure (HF) hospitalization or cardiovascular death with vericiguat relative to placebo in high‐risk HF. This study aimed to contextualize treatment effects of vericiguat in populations with varying risk profiles simulated from the PARADIGM ...
Veraprapas Kittipibul, Robert J. Mentz, Rebecca Young, Javed Butler, Justin A. Ezekowitz, Carolyn S.P. Lam, Piotr Ponikowski, Adriaan Voors, Stefano Corda, Ciaran McMullan, Christopher M. O'Connor, Kevin J. Anstrom, Paul W. Armstrong, for the VICTORIA Study Group   +13 more
wiley   +1 more source

Barely There But Existent: Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema. [PDF]

Cureus
Butt MA, Kumar S, Sarwer SM, Manna D.
europepmc   +1 more source

Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor-associated angioedema

, 2008
James Brian Byrd, Stephanie Harris, James S. Gainer, Chang Yu, Ajai Shreevatsa, Pradeep Putlur, Karine Touzin, Marshall Summar, A. Adam, Nancy J. Brown   +9 more
openalex   +1 more source

Patterns of Use of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Among Patients With Acute Myocardial Infarction in China From 2001 to 2011: China PEACE‐Retrospective AMI Study [PDF]

, 2015
Jiamin Liu, Frederick A. Masoudi, John A. Spertus, Qing Wang, Karthik Murugiah, Erica S. Spatz, Jing Li, Xi Li, Joseph S. Ross, Harlan M. Krumholz, Lixin Jiang   +10 more
openalex   +1 more source

Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2

Cell, 2020
Ren-di Jiang, Meiqin Liu, Ying Chen, Chao Shan, Yiwu Zhou, Xurui Shen, Qian Li, Lei Zhang, Yan Zhu, Hao-rui Si, Qi Wang, J. Min, Xi Wang, Wei Zhang, Bei Li, Hua-jun Zhang, R. Baric, P. Zhou, Xing-Lou Yang, Zhènglì Shí   +19 more
semanticscholar   +1 more source

Epidemiology of hospitalized heart failure in France based on national data over 10 years, 2012–2022

ESC Heart Failure, Volume 12, Issue 2, Page 1283-1294, April 2025.
Abstract Aims We aim to describe the incidence of HF hospitalization in France in the post‐pandemic era, the prevalence of HF cases and patients' characteristics, management and outcomes while focusing on sex, age and socio‐economic differences and to analyse time‐trends between 2012 and 2022.
Valérie Olié, Richard Isnard, Françoise Pousset, Clémence Grave, Jacques Blacher, Amélie Gabet   +5 more
wiley   +1 more source

Angiotensin-Converting Enzyme Inhibitors and Metabolic Aging: A Drosophila Perspective. [PDF]

Biomolecules
Vecchie' D, Faber VG, Jumbo-Lucioni P, Anholt RRH, Mackay TFC, De Luca M.   +5 more
europepmc   +1 more source

Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction

ESC Heart Failure, Volume 12, Issue 2, Page 912-922, April 2025.
Abstract Aims Few data are available regarding the role of tricuspid annulus plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP), a measurement of right ventricular to pulmonary artery coupling, in patients with chronic heart failure and left ventricular systolic dysfunction.
Mauro Riccardi, Matteo Pagnesi, Rossana Corso, Antonio M. Sammartino, Daniela Tomasoni, Riccardo M. Inciardi, Carlo M. Lombardi, Marianna Adamo, Savina Nodari, Marco Metra   +9 more
wiley   +1 more source

Exploiting the angiotensin-converting enzyme pathway to augment endogenous opioid signaling. [PDF]

Commun Biol
Dobariya P, Williams J, Hanak F, Rothwell PE, More SS.   +4 more
europepmc   +1 more source